alpha7 Nicotinic receptor agonist-1 (Preparation 5) is an alpha7 nAChR agonist. alpha7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimers disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder)[1].
Molekulargewicht:
231.29
Reinheit:
99.70
CAS Nummer:
[220100-05-0]
Formel:
C13H17N3O
Target-Kategorie:
nAChR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten